- OMXSPI 0.97% 795.37
- FN25 1.29% 2239.33
- OMXS30 0.83% 2155.49
WntResearch
Spotlight Stock Market
0.24
0.01 5.65 %
Stock information
- Company WntResearch
- Currency SEK
- Turnover 176 039 SEK
- % 5.65
- + / - 0.01
- Buy -
- Sell -
- High 1.08
- Low -
- Last updated 2023-09-29 17:25
Company information
WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.
- Number of shares 305 Millions
- Stock market value 74 MSEK
- Average daily turnover 673 TSEK
- CEO Pernilla Sandwall
- Chairman of the Board Christer Nordstedt
- Volatility 30 days 79.33%
- Volatility 200 days 112.22%
- Dividend -
- Latest annual report -
- Absolute return -
Owners
| Name | Ownership | Last modified |
|---|---|---|
| Försäkringsaktiebolaget, Avanza Pension | 11.9% | 2023-06-30 |
| Nordnet Pensionsförsäkring AB | 6.3% | 2023-06-30 |
| Thomas Mellqvist | 2.1% | 2023-06-30 |
| Gunvald Berger | 2% | 2023-06-30 |
| Stenberg, Kjell | 1.7% | 2023-06-30 |
| Evertsson, Niclas | 1.5% | 2023-06-30 |
| Forsgårdh, Lars Erik Georg | 1.5% | 2023-06-30 |
| Christian Haarlem | 1.2% | 2023-06-30 |
| Peter Nero | 1.1% | 2023-06-30 |
| Stefan Malmkvist | 1% | 2023-06-30 |